CMA may sustain the Warburg effect in cancer cells [53] either indirectly by targeting p53 and thus reducing p53-dependent transcription of key glycolytic enzymes such as GAPDH and aldolase [52], or directly by targeting key glycolytic enzymes such as acetylated PKM2 [54] and HK2 [55]. Here, TP53 is linked to cancer.